Maa: Yhdysvallat
Kieli: englanti
Lähde: NLM (National Library of Medicine)
SUCCINYLCHOLINE CHLORIDE (UNII: I9L0DDD30I) (SUCCINYLCHOLINE - UNII:J2R869A8YF)
STI Pharma LLC
INTRAVENOUS
PRESCRIPTION DRUG
Succinylcholine Chloride Injection is indicated in adults and pediatric patients: - as an adjunct to general anesthesia - to facilitate tracheal intubation - to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine Chloride Injection is contraindicated: - in patients with skeletal muscle myopathies [see Warnings and Precautions (5.1)] - in patients with known hypersensitivity to succinylcholine. Severe anaphylactic reactions to succinylcholine have been reported [see Warnings and Precautions (5.2)] - after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, which may result in severe hyperkalemia and cardiac arrest [see Warnings and Precautions (5.4)] - in patients with personal or familial history of malignant hyperthermia [see Warnings and Precautions (5.5)] Risk Summary Available data from published literature from case
Succinylcholine Chloride Injection, USP is supplied as a clear, colorless solution in the following concentration and package: Refrigeration of the undiluted agent will assure full potency until expiration date. All units carry a date of expiration. Store in refrigerator 2° to 8°C (36° to 46°F) . The multi-dose vials are stable for up to 14 days at room temperature without significant loss of potency. Manufactured in India for: STI Pharma LLC Newtown, PA 18940 1.888.301.9680 Revised: 09/2021
Abbreviated New Drug Application
SUCCINYLCHOLINE CHLORIDE- SUCCINYLCHOLINE CHLORIDE INJECTION STI PHARMA LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE SUCCINYLCHOLINE CHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR SUCCINYLCHOLINE CHLORIDE INJECTION. SUCCINYLCHOLINE CHLORIDE INJECTION INJECTION, FOR INTRAVENOUS OR INTRAMUSCULAR USE. INITIAL U.S. APPROVAL: 1952 WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING. ACUTE RHABDOMYOLYSIS WITH HYPERKALEMIA FOLLOWED BY VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH HAS OCCURRED AFTER USE IN APPARENTLY HEALTHY PEDIATRIC PATIENTS WHO WERE SUBSEQUENTLY FOUND TO HAVE UNDIAGNOSED SKELETAL MUSCLE MYOPATHY. (5.1) WHEN A HEALTHY-APPEARING PEDIATRIC PATIENT DEVELOPS CARDIAC ARREST SOON AFTER ADMINISTRATION OF SUCCINYLCHOLINE CHLORIDE INJECTION, NOT FELT TO BE DUE TO OTHER CAUSES, IMMEDIATE TREATMENT FOR HYPERKALEMIA SHOULD BE INSTITUTED. IN THE PRESENCE OF SIGNS OF MALIGNANT HYPERTHERMIA, APPROPRIATE TREATMENT SHOULD BE INSTITUTED CONCURRENTLY. (5.1) RESERVE USE OF SUCCINYLCHOLINE CHLORIDE INJECTION IN PEDIATRIC PATIENTS FOR EMERGENCY INTUBATION OR INSTANCES WHERE IMMEDIATE SECURING OF THE AIRWAY IS NECESSARY, OR FOR INTRAMUSCULAR USE WHEN A SUITABLE VEIN IS INACCESSIBLE. (5.1) RECENT MAJOR CHANGES Boxed Warning 08/2021 Dosage and Administration (2.1) 08/2021 Warnings and Precautions (5.1, 5.2, 5.4, 5.9, 5.10, 5.12, 5.13, 5.14) 08/2021 INDICATIONS AND USAGE INDICATIONS AND USAGE (1) Succinylcholine Chloride Injection, is a depolarizing neuromuscular blocker indicated in adults and pediatric patients: (1) as an adjunct to general anesthesia (1) to facilitate tracheal intubation (1) to provide skeletal muscle relaxation during surgery or mechanical ventilation. (1) (1) DOSAGE AND ADMINISTRATION DOSAGE AND ADMINISTRATION (2) For intravenous or intramuscular use only. (2.1) Individuali Lue koko asiakirja